Wildcat Capital Management’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | – | Sell |
-2,410,034
| Closed | -$433M | – | 18 |
|
2017
Q3 | $433M | Hold |
2,410,034
| – | – | 77.71% | 1 |
|
2017
Q2 | $250M | Buy |
2,410,034
+51,950
| +2% | +$5.39M | 66.42% | 1 |
|
2017
Q1 | $185M | Hold |
2,358,084
| – | – | 58.62% | 1 |
|
2016
Q4 | $106M | Hold |
2,358,084
| – | – | 48.63% | 1 |
|
2016
Q3 | $132M | Hold |
2,358,084
| – | – | 39.7% | 1 |
|
2016
Q2 | $118M | Hold |
2,358,084
| – | – | 44.43% | 1 |
|
2016
Q1 | $108M | Hold |
2,358,084
| – | – | 37.65% | 1 |
|
2015
Q4 | $145M | Hold |
2,358,084
| – | – | 41% | 1 |
|
2015
Q3 | $131M | Hold |
2,358,084
| – | – | 49.02% | 1 |
|
2015
Q2 | $144M | Hold |
2,358,084
| – | – | 49.28% | 1 |
|
2015
Q1 | $136M | Hold |
2,358,084
| – | – | 52.71% | 1 |
|
2014
Q4 | $136M | Buy |
+2,358,084
| New | +$136M | 55.97% | 1 |
|